Table 3.
Multivariate Analyses for Characteristics Related to Overall Survival
| Characteristics | Training Set | Testing Set | Validation Set | |||
|---|---|---|---|---|---|---|
| HR (95%CI) | P-value | HR (95%CI) | P-value | HR (95%CI) | P-value | |
| Immunotype | 0.005* | 0.007* | 0.005* | |||
| Type A | 1.000 (reference) | 1.000 (reference) | 1.000 (reference) | |||
| Type B | 2.068 (1.243–3.440) | 2.028 (1.210–3.397) | 6.474 (1.744–24.038) | |||
| pTNM stage | 0.048* | 0.430 | 0.104 | |||
| I | 1.000 (reference) | 1.000 (reference) | 1.000 (reference) | |||
| II | 6.756 (0.851–53.638) | 0.591 (0.241–1.452) | 0.659 (0.137–3.160) | |||
| III | 11.534 (1.337–99.486) | 0.820 (0.304–2.211) | 1.657 (0.334–8.221) | |||
| LVI | 0.304 | 0.141 | – | |||
| Negative | 1.000 (reference) | 1.000 (reference) | – | |||
| Positive | 1.624 (0.645–4.089) | 1.823 (0.820–4.052) | – | |||
| Gender | – | – | 0.245 | |||
| Female | – | – | 1.000 (reference) | |||
| Male | – | – | 2.563 (0.524–12.538) | |||
Notes: The variables identified with statistical significance were included into the multivariate analysis. *P<0.05.